These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6055855

  • 1. [Study of an attenuated strain of infectious myxoma virus obtained by passage in cell cultures (MacKercher and Saito, 1964)].
    Jacotot H, Virat B, Reculard P, Vallée A, Le Bouquin MJ, Boutry JM, Gobert D.
    Ann Inst Pasteur (Paris); 1967 Aug; 113(2):221-37. PubMed ID: 6055855
    [No Abstract] [Full Text] [Related]

  • 2. [On a strain of Sanarelli virus attenuated by passage through cell cultures].
    Jacotot H, Virat B, Reculard P, Vallée A.
    Bull Acad Vet Fr; 1967 May; 40(5):255-60. PubMed ID: 5595260
    [No Abstract] [Full Text] [Related]

  • 3. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P, Botti G, Barbieri I, Lavazza A, Capucci L.
    Vaccine; 2010 Jul 26; 28(33):5414-20. PubMed ID: 20598407
    [Abstract] [Full Text] [Related]

  • 4. [Morphogenesis of the rabbit myxomatosis virus].
    Tektoff J, Gazzolo L, Leftheriotis E.
    Pathol Biol (Paris); 1971 Dec 26; 19(23):1045-54. PubMed ID: 4945755
    [No Abstract] [Full Text] [Related]

  • 5. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D.
    Tijdschr Diergeneeskd; 2010 Mar 01; 135(5):194-8. PubMed ID: 20334023
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
    Marlier D, Mainil J, Boucraut-Baralon C, Linden A, Vindevogel H.
    J Comp Pathol; 2000 Mar 01; 122(2-3):115-22. PubMed ID: 10684680
    [Abstract] [Full Text] [Related]

  • 7. [Myxomatosis of rabbits--study of virus modification].
    Jiran E, Sladká M, Kunstýr I.
    Zentralbl Veterinarmed B; 1970 Mar 01; 17(3):418-28. PubMed ID: 5516854
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Myxomatosis vaccine.
    Lawton MP.
    Vet Rec; 1992 May 02; 130(18):407-8. PubMed ID: 1609472
    [No Abstract] [Full Text] [Related]

  • 10. [Study of attenuated strain of myxoma virus].
    Maral R.
    C R Acad Hebd Seances Acad Sci D; 1970 Aug 24; 271(8):737-9. PubMed ID: 4992294
    [No Abstract] [Full Text] [Related]

  • 11. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ, Perkins HD, Inglis B, Stagg R, McLaughlin E, Collins SV, Van Leeuwen BH.
    Virology; 2004 Jun 20; 324(1):117-28. PubMed ID: 15183059
    [Abstract] [Full Text] [Related]

  • 12. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild.
    Ferreira C, Ramírez E, Castro F, Ferreras P, Alves PC, Redpath S, Villafuerte R.
    Vaccine; 2009 Nov 23; 27(50):6998-7002. PubMed ID: 19800438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. AN OUTBREAK OF MYXOMATOSIS CAUSED BY A MODERATELY ATTENUATED STRAIN OF MYXOMA VIRUS.
    CHAPPLE PJ, LEWIS ND.
    J Hyg (Lond); 1964 Dec 23; 62(4):433-41. PubMed ID: 14239923
    [No Abstract] [Full Text] [Related]

  • 15. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective.
    Adams MM, van Leeuwen BH, Kerr PJ.
    Vaccine; 2004 Nov 25; 23(2):198-204. PubMed ID: 15531037
    [Abstract] [Full Text] [Related]

  • 16. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.
    Best SM, Kerr PJ.
    Virology; 2000 Feb 01; 267(1):36-48. PubMed ID: 10648181
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations.
    Farsang A, Makranszki L, Dobos-Kovács M, Virág G, Fábián K, Barna T, Kulcsár G, Kucsera L, Vetési F.
    Acta Vet Hung; 2003 Feb 01; 51(4):493-501. PubMed ID: 14680061
    [Abstract] [Full Text] [Related]

  • 18. Control of rabbit myxomatosis in Poland.
    Górski J, Mizak B, Chrobocińska M.
    Rev Sci Tech; 1994 Sep 01; 13(3):869-79. PubMed ID: 7949359
    [Abstract] [Full Text] [Related]

  • 19. [Administration of vaccine against myxomatosis using live MXT by means of external ear puncture with a special needle].
    Cupera Z, Krupka V, Jiran E.
    Vet Med (Praha); 1982 Sep 01; 27(10):617-26. PubMed ID: 6815860
    [Abstract] [Full Text] [Related]

  • 20. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G.
    Virology; 1996 Jan 01; 215(1):17-30. PubMed ID: 8553583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.